Search

everythinglearnresearchcommunity

for

Search:↓

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

The paper suggests that hair loss might be caused by skull growth, not just DHT's effect on hair follicles, and calls for more research.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Finasteride treats baldness but may cause lasting sexual side effects.

The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.

IGFBP-rP1 could be a new treatment for a common type of hair loss.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Early-stage male pattern baldness shows two types of hair loss: one on the top of the head linked to hormonal changes, and another at the back of the head. The top hair loss responds well to specific treatment, while the back hair loss does not.

A 14-year-old boy was diagnosed with a rare hair condition that may lead to hair thinning and has no known effective treatments.

Changing hair follicle identity could potentially reverse balding.

Androgens can both increase and decrease hair growth in different parts of the body.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Diazoxide applied to the skin can increase hair growth without harmful side effects.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

Botulinum toxin may help hair loss by increasing blood flow and reducing harmful factors.

Clascoterone may be an effective topical treatment for hair loss.

Male pattern hair loss affects up to 80% of men due to genetics and hormone sensitivity.

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.

Finasteride treats hair loss and prostate issues by lowering certain hormone levels.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Hair loss can be caused by hormones, illness, autoimmune disorders, or vitamin deficiencies, and treatments vary depending on the type.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Higher levels of heat shock protein 27 and lower levels of miR-1 can increase AR levels, leading to hair loss in men.

Androgenetic alopecia is a common type of hair loss in men and women, caused by a testosterone byproduct affecting hair follicles, with sensitivity determined by genetics.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.